<?xml version="1.0" encoding="UTF-8"?>
<p>Significant predictive factors of HCC development in the treatment and no-treatment groups were shown in Table 
 <xref ref-type="table" rid="T4">4</xref>. In the treatment group, older age (HR 1.05, 
 <italic>P</italic> = 0.02), presence of cirrhosis (HR 6.35, 
 <italic>P</italic> &lt; 0.01), and SVR (−) (HR 10.73, 
 <italic>P</italic> &lt; 0.01) independently predicted HCC development (Table 
 <xref ref-type="table" rid="T4">4</xref>). In the no-treatment group, older age (HR 1.03, 
 <italic>P</italic> &lt; 0.01), male (HR 1.68, 
 <italic>P</italic> = 0.02), and presence of cirrhosis (HR 11.64, 
 <italic>P</italic> &lt; 0.01) independently predicted HCC development (Table 
 <xref ref-type="table" rid="T4">4</xref>).
</p>
